Xerostomia Clinical Trial
Official title:
The Effect of Biotene® Oralbalance Moisturizing Gel on the Symptoms of Xerostomia and the Efficiency and Ease of Mastication and Swallowing
This study will compare the effects of Biotene® Oral Balance Moisturizing Gel (Biotene), an over-the-counter artificial saliva, that the effects of a sham condition on oral health-related quality of life, mastication, and swallowing in four groups of participants: 1) Participants not experiencing xerostomia or hyposalivation, 2) Participants experiencing xerostomia and hyposalivation, 3) Participants experiencing xerostomia but not hyposalivation, 4) Participants experiencing hyposalivation but not xerostomia.
Saliva is important for maintaining oral and general health. This complex bioactive substance
serves many functions including i) protecting the oral mucosa, ii) reducing demineralization
and facilitating remineralization of teeth, and iii) sustaining a balanced oral biome and
facilitating antimicrobial actions and clearance of pathogens. Moreover, saliva also plays a
critical role in alimentary functions such as mastication and swallowing.
The role of saliva in the process of mastication and swallowing is complex and is not
currently well understood. The purpose of mastication is to process food in the oral cavity
into a bolus that can be transported through the oropharynx, swallowed safely, and then
easily digested. During mastication, ingested food particles are mechanically reduced in size
through the process of lingual particle selection and fragmentation between the occlusal
surfaces of the teeth. The secretion of saliva is critical for effective mastication, bolus
formation and bolus transport. There is also evidence to suggest that the volume of saliva
secreted into the oral cavity during alimentation may impact swallowing biomechanics.
Oral tissue dryness is a complex issue. Hyposalivation and xerostomia span numerous clinical
pathologies and are known side effects of many therapeutic agents. Hyposalivation occurs when
there are objective signs of a reduction of the amount of saliva produced by the salivary
glands and can be measured using sialometry. Xerostomia refers to the subjective symptoms of
dry mouth and can only be assessed through a person's perception of the presence of symptoms.
A person may experience xerostomia with or without hyposalivation or experience
hyposalivation with or without xerostomia. Hyposalivation is a commonly complaint in older
adults. Additionally, patients with hyposalivation and xerostomia frequently report symptoms
of dysphagia, or difficulty swallowing.
To alleviate symptoms associated with hyposalivation, such as the perception of dry mouth, or
xerostomia, many people use over-the-counter artificial saliva products such as Biotene® Oral
Balance Moisturizing Gel (Biotene). There is, however, a paucity of evidence examining the
effect of these products on oral health-related quality of life, mastication, and swallowing.
The goal of this study therefore, is to compare the effects of Biotene® Oral Balance
Moisturizing Gel (Biotene) with the effects of a sham condition on oral health-related
quality of life, masticatory efficiency, and perceived swallowing effort in four groups of
participants: 1) Participants not experiencing xerostomia or hyposalivation, 2) Participants
experiencing xerostomia and hyposalivation, 3) Participants experiencing xerostomia but not
hyposalivation, 4) Participants experiencing hyposalivation but not xerostomia.
It is hypothesized that, following the application of Biotene® Oralbalance Moisturizing Gel,
all groups of participants will experience improved oral health-related quality of life,
improved masticatory efficiency a reduction in perceived swallowing effort. The reduction
will be significant when compared with that of the sham condition. Participants with
xerostomia and/or hyposalivation will demonstrate greater improvement in oral health-related
quality of life, improvement in masticatory efficiency, and reduction in perceived swallowing
effort compared with those who do not experience xerostomia and/or hyposalivation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05342272 -
Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction
|
Phase 3 | |
Completed |
NCT03302676 -
The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors
|
N/A | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Completed |
NCT01272570 -
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
|
N/A | |
Completed |
NCT00656513 -
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00911768 -
Effect of Korean Red Ginseng (KRG) on Dry Mouth
|
Phase 4 | |
Completed |
NCT00332618 -
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
|
Phase 2 | |
Completed |
NCT03494985 -
A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water
|
N/A | |
Completed |
NCT05058430 -
SaliPen Human Factors Study for OTC Labeling
|
N/A | |
Recruiting |
NCT02705937 -
Early Phase Study Comparing the Effectiveness of a Dairy Product With the Reference Treatment Aequasyal® on Dry Mouth Symptoms in Patients Suffering From Xerostomia Caused by Psychotropic Medications.
|
N/A | |
Completed |
NCT05247008 -
Effectiveness of Thyme Honey in Management of Xerostomia in ESRD
|
N/A | |
Recruiting |
NCT03632096 -
Photobiomodulation in Salivary Production of Patients With Xerostomy
|
Phase 2 | |
Not yet recruiting |
NCT03530735 -
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
|
N/A | |
Active, not recruiting |
NCT03176368 -
Coconut Oil: Managing Radiation-Induced Xerostomia
|
N/A | |
Enrolling by invitation |
NCT06122636 -
Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC
|
N/A | |
Completed |
NCT03611283 -
Topical Management of Xerostomia With Dry Mouth Products
|
N/A | |
Completed |
NCT02682199 -
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
|
||
Withdrawn |
NCT01960101 -
Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication
|
N/A | |
Completed |
NCT02317172 -
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
|
N/A | |
Completed |
NCT00350350 -
OGT Spray in the Management of Xerostomia in the Elderly
|
Phase 3 |